- Source type
- Study
- Access type
- Publisher
- Publisher
- Nature Communications
- Date
- 2024
- Added
- 2026-06-19
Trust profile
88
Peer-reviewed research publisher
- Publisher type
- Peer-reviewed journal
- Bias profile
- Moderate
Best used for
- Primary studies
- Systematic reviews
- Mechanistic research
Weak for
- Regulatory status
- Universal consumer recommendations
Used in Viral Vitalism
GLP-1s, Dopamine, and Addiction: The Substance Use Signal
Roles: Primary source
Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population
Roles: Primary source
Show section-level references
Claims supported
No reusable evidence claims are currently attached to this source.
Related studies
Related sources
Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder
Trial registry for oral semaglutide among adults with AUD.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 1 connection
Does Semaglutide Reduce Alcohol Intake
Trial registry for semaglutide and alcohol intake.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 1 connection
Semaglutide for Alcohol Use Disorder
Trial registry for early-phase semaglutide AUD trial.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 4 connections
Semaglutide Therapy for Alcohol Reduction
Trial registry for semaglutide therapy for alcohol reduction.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 1 connection
Effects of Semaglutide on Nicotine Intake
Trial registry for semaglutide and nicotine intake.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 2 connections
ESSENCE clinical trial registry
ClinicalTrials.gov used across the Viral Vitalism evidence library.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 3 connections
